C187 - Comprehensive Migraine Update I: Migraine Diagnosis, Pathophysiology, and Comorbidities
| Event Time: | Wednesday May 8, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Headache, Foundations in Clinical Neurology for APPs |
| Director(s): | Gretchen Tietjen MD |
| Description: | This course highlights practical methods for diagnosing migraine through presentation of cases, and provides recent insights into the pathophysiological mechanisms of the disorder, including those from a variety of conditions comorbid with migraine. This update is designed to provide a comprehensive understanding of migraine with an emphasis on chronic migraine. This program complements Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies, but covers independent topics. |
| Completion Message: | Participants should be able to apply criteria for the clinical diagnosis and differential diagnosis of migraine, both chronic and episodic, using diagnostic algorithms; describe emerging insights into the pathophysiology of migraine; and recognize the scope, burden, and distribution of chronic migraine in the population, as well as the risk factors that predispose to it, and the comorbidities associated with it. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:10 PM | Introduction | Gretchen E. Tietjen MD |
| 1:10 PM - 1:40 PM | Diagnosis of Migraine | Morris Levin MD, FAAN |
| 1:40 PM - 2:10 PM | Migraine Pathophysiology | Stewart J. Tepper MD |
| 2:10 PM - 2:40 PM | Epidemiology, Progression, and Comorbidity | Richard B. Lipton MD, FAAN |
| 2:40 PM - 3:00 PM | Panel Discussion/Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Morris Levin, MD, FAAN | Dr. Levin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Lilly, Teva, Alder, Theranica. |
| Richard B. Lipton, MD, FAAN | Dr. Lipton has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, and Vedanta. Dr. Lipton has received compensation for serving on the Board of Directors of eNeura and Biohaven. Dr. Lipton holds stock and/or stock options in Biohaven, which sponsored research in which Dr. Lipton was involved as an investigator. Dr. Lipton holds stock and/or stock options in Biohaven. Dr. Lipton has received research support from Migraine Research Foundation, the National Headache Foundation, and Amgen. |
| Stewart J. Tepper, MD | Dr. Tepper has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stewart J. Tepper, MD, has consulted for Acorda, Alder, Allergan, Amgen, ATI, Avanir, BioVision, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, GLG, Guidepoint Global, Novartis, Pernix, Pfizer, Scion, Supernus, Teva, and Zosano. Dr. Tepper has received personal compensation in an editorial capacity for Headache Currents from AHS. Dr. Tepper has received royalty, license fees, or contractual rights payments from royalties for books published by Springer. Dr. Tepper has received research support from His employer, Dartmouth-Hitchcock Medical Center, American Headache Society (AHS), receives research grants from Adler, Allergan, Amgen, ATI, Dr. Reddy’s, Scion, Teva, and Zosano. . |
| Gretchen E. Tietjen, MD | Dr. Tietjen holds stock and/or stock options in Johnson & Johnson, Stryker. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
S59 -
Migraine: Impact, Treatment Patterns and Resource Utilization
|